Intuitive reported second-quarter results that exceeded Wall Street expectations, driven by strong demand for its da Vinci surgical systems. The company posted $658.4 million in net income, or $1.81 per share, on revenue of $2.44 billion—marking a 25% profit increase and 21.4% growth in sales compared to Q2 2024.
Adjusted earnings reached $2.19 per share, outperforming analyst forecasts by 26¢. Revenue also surpassed projections of $2.35 billion. Sales of da Vinci systems rose 17% year over year, with 395 systems placed globally during the quarter, up from 341 in the same period last year. Notably, placements of the new da Vinci 5 nearly tripled from 70 to 180 units.
CEO Dave Rosa attributed the strong performance to continued adoption of both legacy and next-generation platforms, emphasizing the company’s focus on improving outcomes, expanding access, and reducing care costs. Looking ahead, Intuitive expects da Vinci procedure volumes to grow 15.5–17% in 2025, with non-GAAP gross margins of 66–67%, including a 1% revenue impact from tariffs.
Follow MEDWIRE.AI for surgical robotics insights and market updates.
